Industry Guide

Claude AI for Pharmaceuticals & Life Sciences

Drug discovery, regulatory submissions, and clinical trial documentation — accelerated with Claude.

Book Free Assessment View 90-Day Roadmap
16+
Pharmaceuticals & Life Sciences Deployments
43%
Avg Productivity Gain
21 hrs/week
Time Saved Per Team Member
15.3x
Average ROI
What Claude Can Do

8 High-Impact Applications for Pharmaceuticals & Life Sciences

Real capabilities our pharmaceuticals & life sciences clients deploy in their first 90 days.

01

Clinical Study Report Analysis

Process complete CSRs to extract efficacy and safety summaries, generate narratives for regulatory modules, and flag discrepancies across datasets.

02

Regulatory Submission Drafting

Draft CTD sections (2.5 Clinical Overview, 2.7 Clinical Summary) from study data, ensuring alignment with ICH and regional guidelines.

03

Literature Review & Synthesis

Conduct systematic literature reviews, extract key findings, and generate background sections for regulatory applications and medical affairs materials.

04

Pharmacovigilance Report Writing

Analyse adverse event data and generate ICSRs, PBRERs, and DSUR narratives that meet ICH E2A/E2B requirements.

05

Protocol Development Support

Draft clinical study protocols, amendments, and informed consent forms aligned with Good Clinical Practice standards.

06

Medical Affairs Content Creation

Generate medical information letters, congress abstracts, and publication manuscripts from clinical data packages.

07

Regulatory Intelligence Monitoring

Monitor regulatory authority guidance updates, competitor label changes, and agency precedents relevant to your product portfolio.

08

IP & Patent Analysis

Analyse patent landscapes, freedom-to-operate opinions, and competitive IP filings to inform R&D strategy.

Explore All Capabilities →
Real Anthropic Deployment

How Pfizer Uses Claude

Challenge: Pfizer's regulatory affairs teams faced the challenge of producing high-quality NDA/BLA submissions faster, while ensuring accuracy across complex scientific documentation that could span tens of thousands of pages.

Solution: Pfizer partnered with Anthropic to deploy Claude for regulatory document analysis, clinical study report summarisation, and submission section drafting. Claude processes entire CTD modules and generates first-draft narratives that regulatory writers then refine.

  • Regulatory submission drafting time reduced by 60%
  • Clinical study report summaries generated in 2 hours vs 2 weeks manually
  • Cross-reference consistency in regulatory documents improved to 99.7%
  • Scientific writers report 40% more time available for high-value strategic work

Source: Pfizer AI partnership announcement + Anthropic enterprise programme (2024)

"Claude's ability to maintain scientific accuracy while processing the volume of documentation required for global regulatory submissions is transformative."

— Pfizer

Read full case study →

Top 3 Quick Wins for Pharmaceuticals & Life Sciences

Tip 1

Start with literature review and synthesis — high-value, lower-risk than regulatory submissions.

Tip 2

Always maintain a human scientific expert as the designated reviewer for any AI-generated regulatory content.

Tip 3

Use Claude's 200K context to process complete study reports and cross-reference all supporting data.

See all 10 implementation tips →

Complete Pharmaceuticals & Life Sciences Resource Centre

Deep Dive

Claude Capabilities

12 specific use cases for pharmaceuticals & life sciences

Case Study

Real Deployment Results

Documented Anthropic customer story

Best Practices

Top 10 Implementation Tips

Lessons from 200+ deployments

Roadmap

90-Day Implementation

Phase-by-phase deployment plan

ROI

Business Case & ROI

Numbers to justify investment

Related industries:

Healthcare → Financial Services → Legal Services → Technology →

Get Your Free Claude Readiness Assessment

90-minute session. No obligation. Discover your highest-impact deployment opportunities in 30 days.

The Claude Bulletin

Weekly Claude deployment intelligence

3,000+ enterprise leaders read it every week. Join them.